Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDry skin is reported by some people taking Mounjaro, though it is not listed among the most common side effects in the licensed product information. The more likely culprit, in most cases, is reduced fluid and food intake rather than tirzepatide acting directly on skin cells. That said, skin changes on Mounjaro deserve a proper look, because the cause shapes the fix. These are prescription-only medicines, and any persistent or troubling skin change is worth raising with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The assumption that lands in most online discussions is that tirzepatide must be doing something directly to skin barrier function. It is an understandable leap. You start a new medicine, your skin feels tight and flaky, so you connect the two. But the NHS medicines information for tirzepatide does not include dry skin in its common or uncommon side-effect list. What it does list prominently are gastrointestinal effects (nausea, reduced appetite, slower gastric emptying) and those are exactly the mechanisms that lead, indirectly, to skin changes for some people.
Mounjaro works partly by signalling fullness sooner and slowing the rate at which food leaves the stomach. Both effects are intentional. For weight management they are useful. But they also mean many people on treatment eat and drink noticeably less, particularly in the early weeks of each dose step. Less fluid in means less fluid available for skin. That is not a pharmacological attack on your skin; it is a downstream consequence of eating and drinking less.
If you have been wondering whether Mounjaro directly causes dry skin or whether something else is at play, the distinction matters because it shapes how you respond to the problem. Reduced thirst is a known companion to reduced appetite, so the usual hunger-and-thirst cues that prompt drinking can both quieten together.
Dehydration is the most straightforward explanation for dry skin that appears after starting tirzepatide. When calorie intake drops steeply (which is common in the first weeks after a dose increase) the body loses glycogen stores, and glycogen is stored with water. That fluid loss, combined with simply drinking less, can leave skin visibly drier within days. The effect tends to be most noticeable around dose increases rather than settling periods, which fits the pattern people describe.
Rapid weight loss itself can also affect skin texture and elasticity. As fat stores beneath the skin shrink, the skin adapts. This is a normal physiological response rather than a sign something has gone wrong. You can read more about the range of skin changes reported during Mounjaro treatment and how they compare to what the clinical data shows.
A third, less common possibility is contact dryness or irritation at the injection site. Repeated injections in the same small area, combined with alcohol-swab use, can locally disrupt the skin barrier. Rotating injection sites (abdomen, thigh, upper arm) and waiting until the skin is fully dry after cleaning before injecting can help. More on injection-site skin soreness is available if that matches what you are experiencing.
Rarely, thyroid function changes associated with significant weight loss can affect skin — but this is not specific to tirzepatide and would be investigated through your GP rather than managed with moisturiser.
Hydration is the first lever. Aiming for around two litres of water daily is a useful starting point, though individual needs vary; your prescriber or dietitian can give you a personal target. If plain water feels unappealing while nausea is present, small sips of diluted squash or clear broth count. Protein adequacy also matters: during rapid weight loss, insufficient dietary protein can impair the skin's ability to repair and retain moisture. Getting enough at each meal, even when portions are small, is genuinely important and a question worth putting to your prescriber at your next check-in.
Topically, a fragrance-free moisturiser applied to damp skin after showering will do more than one applied to dry skin. There is nothing about tirzepatide that makes standard skincare less effective. If the dryness is specifically around the injection site, keeping that area well-moisturised between doses and rotating sites consistently is the right approach.
If you are on tirzepatide privately and are unsure whether your dose schedule is contributing to the problem, your prescriber is the right first contact. At a regulated pharmacy service, that conversation is part of ongoing care, not an extra step. Details of how nume's prescribers handle aftercare queries are on the about us page.
Most dryness linked to lower fluid intake improves once hydration is addressed and the body adjusts to the new dose. There are situations, though, where a skin change warrants a proper clinical assessment rather than home management. Redness, swelling, itching, or raised patches at or away from the injection site could indicate an allergic or inflammatory response, that is different from simple dryness and should not be left to resolve on its own. A rash or unusual skin reaction on Mounjaro is covered separately with more detail on what to watch for.
Cracked or broken skin that is not healing, significant worsening despite good hydration, or skin changes accompanied by other symptoms (fatigue, swelling elsewhere, changes in hair or nails) are all reasons to speak to your GP rather than continuing to self-manage. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk allows patients to report suspected side effects from any medicine, including tirzepatide, which carries Black Triangle status for additional monitoring. Reporting unexpected skin effects there contributes to the ongoing safety picture for all patients.
For a broader overview of the skin-related effects associated with tirzepatide, or to ask a prescriber directly about what you are noticing, a free consultation is a reasonable next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.